The selector needs to define all potential categories of users who will access the product, secure a lease, or purchase options that will provide such access and modify the license agreement
as needed to allow such access.
Lynn went on to say that the company has now distributed franchise disclosure documents to its franchisees reflecting the terms of the new agreement, and he anticipates completing the distribution of actual license agreements
in the next few days.
Structuring Patent Licensing Transactions is an authoritative, insiders perspective on key strategies for creating and negotiating patent license agreements
on behalf of clients.
The license agreement
allows bcgi to continue business, including the sale of its real-time prepaid billing product, without the burden of any infringement claim by Freedom Wireless.
Subject to the terms of the master license agreement
, EPPL has 90 days to comply with certain performance criteria in order to confirm its exclusivity.
Under the License Agreement
, Elan's NanoCrystal Technology may be utilized in the combination product in order to optimize bioavailability and absorption in patients.
The terms of the License Agreement
are that ESPRE will receive $2 Million for providing an exclusive license to ESPRE's technology for MDS' target markets.
The most recent announcements included an expansion of an earlier exclusive license agreement
between The Fashion House and Bill Blass, doubling the number of Bill Blass collections from two to four.
Many of these companies simply do not have the resources -- both financial and human -- to interpret software license agreements
and establish very costly compliance initiatives, largely because of the unnecessary complexities of the license agreements
created by the software industry.
Nasdaq:GILD) today announced that the company has signed non-exclusive license agreements
to provide generic versions of tenofovir disoproxil fumarate (sold by Gilead under the brand name Viread(R)) to three generic manufacturers in India.
STOCKHOLM, Sweden -- Medivir AB (STO:MVIRB) announced today the signing of two new pharmaceutical license agreements
and an extension of the ongoing research collaboration in hepatitis C (HCV) with Tibotec Pharmaceuticals Ltd.
In light of the early validation of the MMP Portfolio by license agreements
with marquee chip-makers Intel and AMD in 2005, followed by the announcement of a license with HP in early 2006, MMP licensing efforts are now focused on global system manufacturers.